NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $778 | +21.6% | 937,223 | +2.5% | 0.00% | 0.0% |
| Q1 2023 | $640 | +5.4% | 914,613 | -23.4% | 0.00% | 0.0% |
| Q4 2022 | $607 | -99.9% | 1,193,447 | -17.2% | 0.00% | 0.0% |
| Q3 2022 | $923,000 | -44.5% | 1,442,067 | -10.7% | 0.00% | -50.0% |
| Q2 2022 | $1,663,000 | -30.3% | 1,614,260 | +27.2% | 0.00% | -33.3% |
| Q1 2022 | $2,386,000 | -41.3% | 1,268,969 | +50.4% | 0.00% | -40.0% |
| Q4 2021 | $4,066,000 | -25.7% | 843,612 | +11.5% | 0.01% | -28.6% |
| Q3 2021 | $5,472,000 | +2.9% | 756,892 | +31.4% | 0.01% | 0.0% |
| Q2 2021 | $5,316,000 | -30.1% | 575,992 | -6.8% | 0.01% | -22.2% |
| Q1 2021 | $7,607,000 | -29.3% | 617,937 | -19.0% | 0.01% | -25.0% |
| Q4 2020 | $10,754,000 | +7.0% | 762,692 | -8.9% | 0.01% | +20.0% |
| Q3 2020 | $10,046,000 | -41.8% | 837,137 | -19.5% | 0.01% | -33.3% |
| Q2 2020 | $17,269,000 | +79.1% | 1,040,292 | +22.8% | 0.02% | +66.7% |
| Q1 2020 | $9,640,000 | +8.8% | 847,092 | +17.8% | 0.01% | +28.6% |
| Q4 2019 | $8,863,000 | +305.1% | 719,386 | -6.3% | 0.01% | +250.0% |
| Q3 2019 | $2,188,000 | – | 767,841 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |